10:40 AM EDT, 03/14/2024 (MT Newswires) -- Tilray Brands ( TLRY ) said Thursday Tilray Medical has received approval for its first medical cannabis extract in Portugal.

The newly approved Tilray Oral Solution THC 5 CBD 20 extract is scheduled to be launched in late spring and will provide new therapeutic options for patients with specified medical conditions, the company said.

Tilray Brands ( TLRY ) shares were down nearly 2% in recent trading.

Price: 1.64, Change: -0.03, Percent Change: -1.88